Phase II Study of Carboplatin and Bevacizumab (Avastin) for ER Neg, PR Neg, and HER2/Neu Neg Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
A Study of Trastuzumab Emtansine (Trastuzumab-MCC-DM1) Administered Intravenously to Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
PTC299 and Hormonal Agent for Treatment of Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
ZD6474 (Zactima) and Metronomic Chemotherapy in Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Capecitabine (Xeloda) and Lapatinib (Tykerb) as First-line Therapy in HER2/Neu-positive Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Phase II Combination of Trastuzumab and Ixabepilone Versus Trastuzumab and Docetaxel in Patients With Advanced and/or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine/Vinorelbine Versus Gemcitabine/Cisplatin Versus Gemcitabine/Capecitabine in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Lapatinib in Combination With Capecitabine in Japanese Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase Ⅱ Clinical Study of R435 (Bevacizumab) in Combination With Paclitaxel in Patients With Inoperable Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
First Line Therapy for Patients With Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Phase I/II Clinical Trial Assessing Safety and Efficacy of BZL101 for Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast Cancer Progressing After Endocrine Treatment
- Status
- TERMINATED
- Phase
- PHASE2
Doxorubicin HCL Liposome Injection (DOXIL) in Combination With Abraxane in Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Sunitinib in Combination With Bevacizumab and Paclitaxel in Previously Untreated Patients With Metastatic Breast Cancer (SABRE-B)
- Status
- TERMINATED
- Phase
- PHASE2
VinCaT: Vinorelbine, Carboplatin and Trastuzumab in Advanced Her-2 Positive Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
- Status
- COMPLETED
- Phase
- NA
Efficacy and Safety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Standard Versus Continuous Capecitabine in Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Phase 2 Neoadjuvant Doxorubicin and Cyclophosphamide -> Docetaxel With Lapatinib in Stage II/III Her2Neu+ Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase 2 Study of Gemzar, Taxol & Avastin Combination as 1st Line Treatment for Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2